|
National Stock Number(NSN): 6505-00-941-2657 (6505009412657, 009412657)
| NIIN: |
00-941-2657 |
Item Name: |
MEPROBAMATE TABLETS |
INC: |
30815
|
| FSC: |
6505
|
Assignment Date: |
Dec-11-1965 |
CRIT: |
X |
IIG: |
30815 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-2024 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9235 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
MILTOWN |
04533
|
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00007-0134-30 |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00037-1001-02 |
04533
|
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00071-0647-32 |
91378
|
PARKE-DAVIS DIV OF WARNER-LAMBERT CO |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00188-1400-10 |
59808
|
KETCHUM LABORATORIES INC STERI-MED INC DIV |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00228-2018-96 |
56287
|
ACTAVIS ELIZABETH LLC |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00781-1410-10 |
59043
|
GENEVA PHARMACEUTICALS INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00879-0044-10 |
60964
|
HALSEY DRUG CO INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NEURAMATE |
60964
|
HALSEY DRUG CO INC |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
SK-BAMATE |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| VA |
JVS |
I |
|
S |
Q |
0 |
V |
$0.00 |
BT |
|
------- |
Nov-01-1983 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| VA |
K |
U/I CONTAINS 1000 TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
400.000 MILLIGRAMS MEPROBAMATE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 TABLETS |
| FEAT |
SPECIAL FEATURES |
CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
Replacement & Obsolete Information
| Obsolete NIIN Information |
|